The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded Scripps Research Institute, a nonprofit biomedical research organization, a $529,125 project grant to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder with the goal of discovering targeted therapies. This 3-year award, effective September 30, 2024, will fund research aimed at improving the health and care of military service members, veterans, and their families by advancing the understanding and treatment of neurological disorders. Scripps Research Institute, a renowned leader in biomedical research, will leverage its multidisciplinary expertise in areas like neuroscience, immunology, and drug discovery to conduct this innovative and impactful work.
Generated 12/10/24, 9:31 AM